(October 30, 2024)

Radioisotopes are mainly used for diagnosing cancer, including prostate and breast cancer.

(…)

The shortage of molybdenum-99 is caused by a sudden global disruption of manufacturing capacity, with several of the nuclear reactors used to produce these elements being out of service.

There are six trusted research reactors globally for the supply of molybdenum-99, none of which are in the UK.